CIBC Asset Management Inc has added 213,907 shares of $CLS to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CLS.
CELESTICA Hedge Fund Activity
We have seen 377 institutional investors add shares of CELESTICA stock to their portfolio, and 287 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WHALE ROCK CAPITAL MANAGEMENT LLC removed 2,227,099 shares (-32.4%) from their portfolio in Q2 2025, for an estimated $347,672,424
- WELLINGTON MANAGEMENT GROUP LLP added 1,636,240 shares (+401.7%) to their portfolio in Q2 2025, for an estimated $255,433,426
- BALYASNY ASSET MANAGEMENT L.P. removed 1,584,958 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $247,427,793
- CITADEL ADVISORS LLC removed 1,299,205 shares (-96.8%) from their portfolio in Q2 2025, for an estimated $202,818,892
- ALKEON CAPITAL MANAGEMENT LLC removed 1,230,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $192,015,300
- BNP PARIBAS FINANCIAL MARKETS removed 985,406 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $153,831,730
- JERICHO CAPITAL ASSET MANAGEMENT L.P. added 962,500 shares (+inf%) to their portfolio in Q2 2025, for an estimated $150,255,875
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CELESTICA Insider Trading Activity
CELESTICA insiders have traded $CLS stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CLS stock by insiders over the last 6 months:
- LAURETTE T KOELLNER has made 4 purchases buying 6,000 shares for an estimated $2,050,025 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CELESTICA Congressional Stock Trading
Members of Congress have traded $CLS stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CLS stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CELESTICA Analyst Ratings
Wall Street analysts have issued reports on $CLS in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 10/29/2025
- CIBC issued a "Outperformer" rating on 10/29/2025
- Stifel issued a "Buy" rating on 10/29/2025
- Barclays issued a "Overweight" rating on 10/29/2025
- RBC Capital issued a "Outperform" rating on 10/22/2025
- JP Morgan issued a "Overweight" rating on 09/08/2025
- CICC issued a "Outperform" rating on 08/19/2025
To track analyst ratings and price targets for CELESTICA, check out Quiver Quantitative's $CLS forecast page.
CELESTICA Price Targets
Multiple analysts have issued price targets for $CLS recently. We have seen 13 analysts offer price targets for $CLS in the last 6 months, with a median target of $350.0.
Here are some recent targets:
- Todd Coupland from CIBC set a target price of $400.0 on 10/29/2025
- Michael Ng from Goldman Sachs set a target price of $440.0 on 10/29/2025
- Paul Treiber from RBC Capital set a target price of $400.0 on 10/29/2025
- George Wang from Barclays set a target price of $357.0 on 10/29/2025
- Samik Chatterjee from JP Morgan set a target price of $360.0 on 10/29/2025
- David Vogt from UBS set a target price of $350.0 on 10/29/2025
- Ruben Roy from Stifel set a target price of $385.0 on 10/29/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $CLS ticker page for more data.
